Advertisement

Topics

FDA Approves Ajovy (fremanezumab-vfrm) for Preventive Treatment of Migraine

18:09 EDT 14 Sep 2018 | Drugs.com

September 14, 2018 -- Today, the US Food and Drug Administration (FDA) approved Ajovy (fremanezumab-vfrm) for the preventive treatment of migraine in adults. Ajovy is the second FDA-approved preventive migraine treatment in a new class of drugs that...

Original Article: FDA Approves Ajovy (fremanezumab-vfrm) for Preventive Treatment of Migraine

NEXT ARTICLE

More From BioPortfolio on "FDA Approves Ajovy (fremanezumab-vfrm) for Preventive Treatment of Migraine"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...